55KRC: UC launches new stroke study

Simply Medicine program highlights clinical trial utilizing mobile stroke units

Researchers at the University of Cincinnati are leading a clinical trial in an effort to find the first proven treatment for stroke due to intracerebral hemorrhage, when blood vessels in the brain rupture and cause bleeding in the brain.

Joseph Broderick, MD, professor in UC’s Department of Neurology and Rehabilitation Medicine in the College of Medicine, director of the UC Gardner Neuroscience Institute and a UC Health physician, is the contact principal investigator for the FASTEST study and spoke with Angenette Levy of 55KRC about it on the weekly radio show and podcast Simply Medicine.

Broderick explained time is of the essence with stroke, so the trial will utilize mobile stroke units to deliver a clotting drug to help "plug the leak" of a brain bleed within two hours of symptoms.

Listen to the Simply Medicine segment. (Note: Segment begins around 30:51 mark.)

Read more about the study.

Featured photo at top of Dr. Broderick. Photo/Joseph Fuqua II/University of Cincinnati

Related Stories

1

6 ways starting a GLP-1 medication could affect your emotions

May 20, 2026

When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.